Obesity and diabetes;Obesidad y diabetes

Nutricion Hospitalaria

Volumn 28, Issue SUPPL.5, 2013, Pages 138-143

  Serván, Pilar Riobó ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

Author keywords

Insulin resistance; Metabolic syndrome; Obesity; Type 2 diabetes

Indexed keywords

HUMAN; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW;

DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME X; OBESITY;

EID: 84883192786     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2013.28.sup5.6929     Document Type: Article

References (24)

1. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-101.
2. Farag MKY, Gaballa MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant 2011; 26: 28-35.
3. Caro JJ, Ward AJ, O'Brien JA. Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. Diabetes Care 2002; 25: 476-81.
4. National Institute of Health: Third report of the National Cholesterol Education Program (NCEP) Expert Panel Detection, Evaluation, and Treatment of High Blood cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
5. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al, American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52.
6. Alberti K, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-80.
7. Creager MA, Lüscher, TF. Diabetes and Vascular Disease. Pathophysiology, Clinical Consequences, and Medical Therapy: Part I. Circulation 2003; 108: 1527-32.
8. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008; 28: 629-36.
9. Balkau B, Charles MA, Drivsholm T, et al. Frequency of the WHO metabolic syndrome in European cohort, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364-76.
10. Ford ES, Mokdad AH, Giles WH, et al. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003; 107: 2185-9.
11. Márquez-Sandoval F, Macedo-Ojeda G, Viramontes-Horner D, Fernández JD, Salas J, Vizmanos B. The prevalence of metabolic syndrome in Latin America: a systematic review Public Health Nutrition. doi:10.1017/S1368980010003320.
12. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005; 51: 931-8.
13. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007; 92: 399-404.
14. Hu G, Lindstrom J, Valle TT, et al. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med 2004; 164: 892-6.
15. Eriksson, KF, Lindgarde, F. Prevention of type 2 (non-insulindependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991; 34: 891.
16. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
17. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393.
18. Kitabchi AE, Temprosa M, Knowler WC, et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 2005; 54: 2404.
19. Davey Smith, G, Bracha Y, Svendsen KH, et al. Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial. Ann Intern Med 2005; 142: 313.
20. Absetz P, Valve R, Oldenburg B. Type 2 Diabetes Prevention in the "Real World". One-year results of the GOAL Implementation Trial. Diabetes Care 2007; 30: 2465-70.
21. Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: Review with meta-analysis of clinical studies. J Am Coll Nutr 2003; 22: 331-9.
22. Psaltopoulou T, Ilias J, Alevizaki M. The Role of Diet and Lifestyle in Primary, Secondary, and Tertiary Diabetes Prevention: A Review of Meta-Analyses. Rev Diabet Stud 2010; 7: 26-35.
23. American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 2010; 32: S11-61.
24. Lloyd-Jones DM, Hong Y, Labarthe D, et al, American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's Strategic Impact Goal through 2020 and beyond. Circulation 2010; 121 (4): 586-613.